Immunisation of mice with mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines

Vaccine

Volumn 31, Issue 1, 2012, Pages 135-140

  Galli, V ^a   Simionatto, S ^a,b   Marchioro, S B ^a   Fisch, A ^a   Gomes, C K ^a   Conceicao F R ^a   Dellagostin, O A ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

Author keywords

Cellular immune response; DNA vaccine; Humoral immune response; Mycoplasma hyopneumoniae; Recombinant subunit vaccine

Indexed keywords

BACTERIAL ANTIGEN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 1; MESSENGER RNA; P37 ANTIGEN; P42 ANTIGEN; P46 ANTIGEN; P95 ANTIGEN; SUBUNIT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INOCULATION; MOUSE; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMAL PNEUMONIA OF SWINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SPLEEN CELL;

ANIMALS; ANTIGENS, BACTERIAL; IMMUNIZATION; MICE; MYCOPLASMA HYOPNEUMONIAE; VACCINES, DNA;

EID: 84870508937     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.088     Document Type: Article

References (29)

1. Sobestiansky J., Barcellos D., Mores N. Pneumonia enzoótica. Clínica e Patologia Suína 1999, Goiás, Goiânia. 2nd ed.
2. Ciprian A., Pijoan C., Cruz T., Camacho J., Tortora J., Colmenares G., et al. Mycoplasma hyopneumoniae increases the susceptibility of pigs to experimental Pasteurella multocida pneumonia. Can J Vet Res 1988, 52:434-438.
3. Ross R.F., Leman A.D., Straw B., Glock R.D., Mengeling W.L., Penny R.H.C., et al. Diseases of swine. Mycoplasma disease 1986, The Iowa State University Press, Ames, IA, p. 469-83.
4. Thacker E.L., Halbur P., Ross R., Thanawongnuweck R., Tracker B. Mycoplasma hyopneumoniae potentiation and respiratory syndrome virus induced pneumonia. J Clin Microbiol 1999, 37:620-627.
5. Thacker E.L., Thacker B.J., Kuhn M., Hawkins P.A., Waters W.R. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am J Vet Res 2000, 61:1384-1389.
6. Chen Y.L., Wang S.N., Yang W.J., Chen Y.J., Lin H.H., Shiuan D. Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination. Infect Immun 2003, 71:1155-1160.
7. Chen A.Y., Fry S.R., Forbes-Faulkner J., Daggard G.E., Mukkur T.K.S. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice. Vet Microbiol 2006, 114:252-259.
8. Babiuk L.A. Vaccination: a management tool in veterinary medicine. Vet J 2002, 164:188-201.
9. Vasconcelos A.T., Ferreira H.B., Bizarro C.V., Bonatto S.L., Carvalho M.O., Pinto P.M., et al. Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. J Bacteriol 2005, 187:5568-5577.
10. Simionatto S., Marchioro S., Galli V., Luerce T., Hartwig D., Moreira A., et al. Efficient site-directed mutagenesis using an overlap extension-PCR method for expressing Mycoplasma hyopneumoniae genes in Escherichia coli. J Microbiol Methods 2009, 79:101-105.
11. Simionatto S., Marchioro S.B., Galli V., Hartwig D.D., Carlessi R.M., Munari F.M., et al. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli. Protein Expr Purif 2010, 69:132-137.
12. Simionatto S., Marchioro S.B., Galli V., Brum C.B., Klein C.S., Silva E.F., et al. Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins. Comp Immunol Microb 2012, 35:209-2016.
13. Marchioro S.B., Simionato S., Galli V., Conceição F.R., Brum C.B., Fish A., et al. Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae. Vet Microbiol 2012, 155:44-52.
14. Chen A.Y., Fry S.R., Daggard G.E., Mukkur T.K. Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice. Vaccine 2008, 26:4372-4378.
15. Ramos C.R.R., Abreu P.A.E., Nascimento A.L.T.O., Ho P.L. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res 2004, 37:1103-1109.
16. Overbergh L., Valckx D., Waer M., Mathieu C. Quantification of murine cytokine mRNAs using real-time quantitative reverse transcriptase PCR. Cytokine 1999, 11:305-312.
17. Cardona P., Gordillo S., Díaz J., Tapia G., Amat I., Pallarés A., et al. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect Immun 2003, 71:5845-5854.
18. Simpson D.A.C., Feeney S., Boyle C., Stitt A.W. Retinal VEGF mRNA measured by SYBR Green I fluorescence: a versatile approach to quantitative PCR. Mol Vis 2000, 6:178-183.
19. -ΔCT method. Methods 2001, 25:402-408.
20. Statistical Analysis System (SAS) SAS user's guide: Statisticas 2004, SAS Institute, Cary, NC.
21. Mosmann T.R., Coffman R.I. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
22. Chen C.H., Wang T.L., Hung C.F., Yang Y., Young R.A., Pardoll D.M., et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000, 60:1035-1042.
23. Maes D., Segales J., Meyns T., Sibila M., Pieters M., Haesebrouck F. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol 2008, 126:297-309.
24. Thanawongnuwech R., Young T.F., Thacker B.J., Thacker E.L. Differential production of proinflammatory cytokines: in vitro PRSSV and Mycoplasma hyopneumoniae co-infection model. Vet Immunol Immunopathol 2001, 79:115-127.
25. Lorenzo H., Quesada O., Assunçao P., Castro A., Rodríguez F. Cytokine expression in porcine lungs experimentally infected with Mycoplasma hyopneumoniae. Vet Immunol Immunopathol 2006, 109:199-207.
26. Conceição F.R., Moreira A.N., Dellagostin O.A. A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice. Vaccine 2006, 24:5734-5743.
27. Okamba F.R., Moreau E., Cheikh Saad Bouh K., Gagnon C.A., Massie B., Arella M. Immune responses induced by replication-defective andenovirus expressing the C-terminal portion of Mycoplasma hyopneumoniae-P97 adhesin. Clin Vaccine Immunol 2007, 14:767-774.
28. Menon S., Wannemuehler M., Mahairas G., Minion F. Mycobacterial ESAT-6 protein enhances mouse INF-γ responses to Mycoplasma hyopneumoniae p71 protein. J Interferon Cytokine Res 2002, 22:807-813.
29. Minion F., Menon S., Mahairas G., Wannemuehler M. Enhanced murine antigen-specific gamma interferon and immunoglobulin G2a responses by using mycobacterial ESAT-6 sequences in DNA vaccines. Infect Immun 2003, 71:2239-2243.